Dual Dehydrosqualene/Squalene Synthase Inhibitors: Leads for Innate Immune System-Based Therapeutics

Lin, Fu-Yang; Zhang, Yonghui; Hensler, Mary; Liu, Yi-Liang; Chow, Ohn A.; Zhu, Wei; Wang, Ke; Pang, Ran; Thienphrapa, Wdee; Nizet, Victor; Oldfield, Eric

doi:10.1002/cmdc.201100589

Title: Dual Dehydrosqualene/Squalene Synthase Inhibitors: Leads for Innate Immune System-Based Therapeutics

Full Record
Other Related Research

Authors:

Lin, Fu-Yang; Zhang, Yonghui; Hensler, Mary; Liu, Yi-Liang; Chow, Ohn A.; Zhu, Wei; Wang, Ke; Pang, Ran; Thienphrapa, Wdee; Nizet, Victor; Oldfield, Eric ^[1]

UIUC

Publication Date:: Wed Sep 18 00:00:00 EDT 2013

Research Org.:: Argonne National Lab. (ANL), Argonne, IL (United States). Advanced Photon Source (APS)

Sponsoring Org.:: USDOE Office of Science (SC)

OSTI Identifier:: 1093492

Resource Type:: Journal Article

Journal Name:: ChemMedChem

Additional Journal Information:: Journal Volume: 7; Journal Issue: (4) ; 04, 2012

Country of Publication:: United States

Language:: ENGLISH

Citation Formats


                    Lin, Fu-Yang, Zhang, Yonghui, Hensler, Mary, Liu, Yi-Liang, Chow, Ohn A., Zhu, Wei, Wang, Ke, Pang, Ran, Thienphrapa, Wdee, Nizet, Victor, Oldfield, Eric, and UCSD). Dual Dehydrosqualene/Squalene Synthase Inhibitors: Leads for Innate Immune System-Based Therapeutics.  United States: N. p., 2013. 
        Web.  doi:10.1002/cmdc.201100589.

Copy to clipboard


                    Lin, Fu-Yang, Zhang, Yonghui, Hensler, Mary, Liu, Yi-Liang, Chow, Ohn A., Zhu, Wei, Wang, Ke, Pang, Ran, Thienphrapa, Wdee, Nizet, Victor, Oldfield, Eric, & UCSD). Dual Dehydrosqualene/Squalene Synthase Inhibitors: Leads for Innate Immune System-Based Therapeutics.  United States.  https://doi.org/10.1002/cmdc.201100589

Copy to clipboard


                    Lin, Fu-Yang, Zhang, Yonghui, Hensler, Mary, Liu, Yi-Liang, Chow, Ohn A., Zhu, Wei, Wang, Ke, Pang, Ran, Thienphrapa, Wdee, Nizet, Victor, Oldfield, Eric, and UCSD). 2013.  
        "Dual Dehydrosqualene/Squalene Synthase Inhibitors: Leads for Innate Immune System-Based Therapeutics".  United States.  https://doi.org/10.1002/cmdc.201100589.

Copy to clipboard


                    
@article{osti_1093492,

  title        = {Dual Dehydrosqualene/Squalene Synthase Inhibitors: Leads for Innate Immune System-Based Therapeutics},

  author       = {Lin, Fu-Yang and Zhang, Yonghui and Hensler, Mary and Liu, Yi-Liang and Chow, Ohn A. and Zhu, Wei and Wang, Ke and Pang, Ran and Thienphrapa, Wdee and Nizet, Victor and Oldfield, Eric and UCSD)},

  abstractNote = {},

  doi          = {10.1002/cmdc.201100589},

  url          = {https://www.osti.gov/biblio/1093492},
  journal      = {ChemMedChem},
number       = (4) ; 04, 2012,

  volume       = 7,

  place        = {United States},

  year         = {Wed Sep 18 00:00:00 EDT 2013},

  month        = {Wed Sep 18 00:00:00 EDT 2013}

}

Copy to clipboard

Journal Article:

https://doi.org/10.1002/cmdc.201100589

Other availability

Find in Google Scholar

Search WorldCat to find libraries that may hold this journal

Save / Share:

Export Metadata

Save to My Library

Similar records in OSTI.GOV collections:

Protective effects of a squalene synthase inhibitor, lapaquistat acetate (TAK-475), on statin-induced myotoxicity in guinea pigs

Journal Article Nishimoto, Tomoyuki; Ishikawa, Eiichiro; Anayama, Hisashi; ... - Toxicology and Applied Pharmacology

High-dose statin treatment has been recommended as a primary strategy for aggressive reduction of LDL cholesterol levels and protection against coronary artery disease. The effectiveness of high-dose statins may be limited by their potential for myotoxic side effects. There is currently little known about the molecular mechanisms of statin-induced myotoxicity. Previously we showed that T-91485, an active metabolite of the squalene synthase inhibitor lapaquistat acetate (lapaquistat: a previous name is TAK-475), attenuated statin-induced cytotoxicity in human skeletal muscle cells [Nishimoto, T., Tozawa, R., Amano, Y., Wada, T., Imura, Y., Sugiyama, Y., 2003a. Comparing myotoxic effects of squalene synthase inhibitor, T-91485,more »« less
https://doi.org/10.1016/j.taap.2007.05.005
Detection of innate immune response modulating impurities (IIRMI) in therapeutic peptides and proteins: Impact of excipients

Journal Article Thacker, Seth; Her, Cheng; Kelley-Baker, Logan; ... - Frontiers in Immunology

Unintended immunogenicity can affect the safety and efficacy of therapeutic proteins and peptides, so accurate assessments of immunogenicity risk can aid in the selection, development, and regulation of biologics. Product- and process- related impurities can act as adjuvants that activate the local or systemic innate immune response increasing the likelihood of product immunogenicity. Thus, assessing whether products have innate immune response modulating impurities (IIRMI) is a key component of immunogenicity risk assessments. Identifying trace levels of individual IIRMI can be difficult and testing individually for all potential impurities is not feasible. Therefore, to mitigate the risk, cell-based assays that usemore »« less
https://doi.org/10.3389/fimmu.2022.970499

Full Text Available
The catalytic mechanism of cyclic GMP-AMP synthase (cGAS) and implications for innate immunity and inhibition: Catalytic Mechanism of cGAS

Journal Article Hall, Justin; Ralph, Erik; Shanker, Suman; ... - Protein Science
https://doi.org/10.1002/pro.3304
The Role of Phosphodiesterase 12 (PDE12) as a Negative Regulator of the Innate Immune Response and the Discovery of Antiviral Inhibitors

Journal Article Wood, Edgar; Bledsoe, Randy; Chai, Jing; ... - Journal of Biological Chemistry

2',5'-Oligoadenylate synthetase (OAS) enzymes and RNase-L constitute a major effector arm of interferon (IFN)-mediated antiviral defense. OAS produces a unique oligonucleotide second messenger, 2',5'-oligoadenylate (2–5A), that binds and activates RNase-L. This pathway is down-regulated by virus- and host-encoded enzymes that degrade 2–5A. Phosphodiesterase 12 (PDE12) was the first cellular 2–5A- degrading enzyme to be purified and described at a molecular level. Inhibition of PDE12 may up-regulate the OAS/RNase-L pathway in response to viral infection resulting in increased resistance to a variety of viral pathogens. We generated a PDE12-null cell line, HeLaΔPDE12, using transcription activator-like effector nuclease-mediated gene inactivation. This cellmore »« less
Cited by 52
https://doi.org/10.1074/jbc.M115.653113

Full Text Available
Dual Regulation of Gene Expression Mediated by Extended MAPK Activation and Salicylic Acid Contributes to Robust Innate Immunity in Arabidopsis thaliana

Journal Article Tsuda, Kenichi; Mine, Akira; Bethke, Gerit; ... - PLoS Genetics

Network robustness is a crucial property of the plant immune signaling network because pathogens are under a strong selection pressure to perturb plant network components to dampen plant immune responses. Nevertheless, modulation of network robustness is an area of network biology that has rarely been explored. While two modes of plant immunity, Effector-Triggered Immunity (ETI) and Pattern-Triggered Immunity (PTI), extensively share signaling machinery, the network output is much more robust against perturbations during ETI than PTI, suggesting modulation of network robustness. Here, we report a molecular mechanism underlying the modulation of the network robustness in Arabidopsis thaliana. The salicylic acidmore »« less
https://doi.org/10.1371/journal.pgen.1004015

Full Text Available

Similar Records